TickerFactsScreenerDevelopers

Insight Molecular Diagnostics Inc. (IMDX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$4.23M2016: -$7.52M2017: -$13.38M2018: -$11.65M2019: -$19.71M2020: -$25.98M2021: -$35.94M2022: -$45.57M2023: -$23.32M2024: -$20.69M2025: -$22.18M-$22.18M
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$22.18M-7.2%
2024-$20.69M+11.3%
2023-$23.32M+48.8%
2022-$45.57M-26.8%
2021-$35.94M-38.3%
2020-$25.98M-31.8%
2019-$19.71M-69.2%
2018-$11.65M+13.0%
2017-$13.38M-77.9%
2016-$7.52M-77.9%
2015-$4.23M—